Chronic Lymphocytic Leukemia: A Review of Front-line Treatment Options, with a Focus on Elderly CLL Patients

Chronic lymphocytic leukemia (CLL) remains the most prevalent form of leukemia in the western world, with no cure to date. Ongoing and essential research into this heterogeneous disease has led to a number of new treatment options becoming available to CLL patients in the last decade. This review looks at the recent developments in the field of CLL treatment, with the main focus on elderly patients and CLL patients with co-existing comorbidities. The review discusses the current treatment regimens which provide the most promising outcomes for patients of this subgroup, with a number of important clinical trials summarized.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Review Article Source Type: research